STOCK TITAN

Federated Hermes (NYSE: FHI) reports 8.42% stake in Scynexis common stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Federated Hermes, Inc. and related reporting persons filed an amended Schedule 13G/A reporting beneficial ownership of 3,533,250 shares of SCYNEXIS, INC. common stock, representing 8.42% of the class as of 12/31/2025. Federated Hermes has sole voting and dispositive power over these shares, while the Voting Shares Irrevocable Trust reports the same sole voting and dispositive power.

Individuals Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue each report shared voting and shared dispositive power over the same 3,533,250 shares and the same 8.42% stake. The filers state the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of SCYNEXIS. They also expressly disclaim beneficial ownership of securities held by the managed funds.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person: In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.


SCHEDULE 13G




Comment for Type of Reporting Person: In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.


SCHEDULE 13G




Comment for Type of Reporting Person: In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.


SCHEDULE 13G




Comment for Type of Reporting Person: In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.


SCHEDULE 13G



Federated Hermes, Inc.
Signature:/s/J. Christopher Donahue
Name/Title:J. Christopher Donahue, as President of Federated Hermes, Inc.
Date:01/08/2026
Voting Shares Irrevocable Trust
Signature:/s/Thomas R. Donahue
Name/Title:Thomas R. Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:01/08/2026
Signature:/s/Ann C. Donahue
Name/Title:Ann C. Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:01/08/2026
Signature:/s/J. Christopher Donahue
Name/Title:J. Christopher Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:01/08/2026
Thomas R. Donahue
Signature:/s/Thomas R. Donahue
Name/Title:Thomas R. Donahue
Date:01/08/2026
Ann C. Donahue
Signature:/s/Ann C. Donahue
Name/Title:Ann C. Donahue
Date:01/08/2026
J. Christopher Donahue
Signature:/s/J. Christopher Donahue
Name/Title:J. Christopher Donahue
Date:01/08/2026

Comments accompanying signature: SEE EXHIBITS 2 AND 3 ATTACHED Exhibit Information EXHIBIT 1 ITEM 3 CLASSIFICATION OF REPORTING PERSONS EXHIBIT 2 AGREEMENT FOR JOINT FILING OF SCHEDULE 13G EXHIBIT 3 POWER OF ATTORNEY

FAQ

What stake does Federated Hermes report in SCYNEXIS (FHI Schedule 13G/A)?

Federated Hermes, Inc. reports beneficial ownership of 3,533,250 shares of SCYNEXIS common stock, representing 8.42% of the outstanding class as of 12/31/2025.

Who are the reporting persons in the Federated Hermes Schedule 13G/A for SCYNEXIS?

The reporting persons are Federated Hermes, Inc., the Voting Shares Irrevocable Trust, and individuals Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue.

How much voting and dispositive power is reported over SCYNEXIS shares?

Federated Hermes, Inc. and the Voting Shares Irrevocable Trust each report 3,533,250 shares with sole voting and sole dispositive power. The three Donahues each report shared voting and shared dispositive power over the same 3,533,250 shares.

Does Federated Hermes intend to influence control of SCYNEXIS according to this filing?

The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of SCYNEXIS.

Do the reporting persons claim full beneficial ownership of the SCYNEXIS shares?

No. Federated Hermes, the Voting Shares Irrevocable Trust, and the Donahues expressly disclaim beneficial ownership of the securities held by the managed funds, in accordance with Rule 13d-4 under the Exchange Act.

What type of securities are covered in this Federated Hermes Schedule 13G/A?

The filing relates to COMMON STOCK of SCYNEXIS, INC. with CUSIP 811292200.
Scynexis

NASDAQ:SCYX

SCYX Rankings

SCYX Latest News

SCYX Latest SEC Filings

SCYX Stock Data

31.72M
41.06M
2.09%
26.58%
1.18%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
JERSEY CITY